7 completed. 7 Phase 1.
By phase and status
Follow CC-90001: new trials by email Literature Review of CC-90001 trials Research Report on CC-90001
Trials (filtered) newest first · largest first
All 7 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid Tumors BMS-986360, Docetaxel, Nivolumab - Advanced Solid Tumors | Phase 1 | Completed | 70 | 2022-12-09 | 2025-06-13 |
A Study of Safety, Tolerability, and Pharmacokinetics of Multiple-Dose CC-90001 in Japanese and Caucasian Healthy Subjects CC-90001 - Healthy Volunteer | Phase 1 | Completed | 60 | 2019-04-04 | 2020-05-08 |
A Study to Assess the Pharmacokinetics of CC-90001 in Subjects With Mild, Moderate, and Severe Hepatic Impairment Compared With Healthy Subjects CC-90001 - Hepatic Impairment | Phase 1 | Completed | 40 | 2018-12-06 | 2020-07-27 |
A Study to Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokinetics of Omeprazole, Midazolam, Warfarin, Rosuvastatin, Metformin, Digoxin, and Nintedanib in Healthy Adult Subjects CC-90001, Omeprazole, Midazolam - Heathy Volunteer | Phase 1 | Completed | 56 | 2017-12-04 | 2019-01-25 |
Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis CC-90001 - Pulmonary Fibrosis | Phase 1 | Completed | 16 | 2015-08-05 | 2017-04-04 |
Effect of UV Exposure on the PD of Multiple Doses of CC-90001 and Pilot Food Effect Study CC-90001 - Healthy Subjects | Phase 1 | Completed | 26 | 2014-11-01 | 2015-08-19 |
First-in-human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of CC-90001 CC-90001, Placebo - Healthy Volunteers | Phase 1 | Completed | 96 | 2014-02-01 | 2014-10-15 |
Conditions studied
Pulmonary Fibrosis (1)
Sponsors
Celgene (4) · Celgene Corporation (2) · Bristol-Myers Squibb (1)
Countries
United States (7) · Australia (2) · Argentina (1) · Canada (1) · Chile (1) · France (1) · Italy (1) · Mexico (1) · Spain (1)
Top investigators
Daniel Weiss, MD (2) · Ed O'Mara, MD (1) · Francisco Ramirez-Valle, MD, PhD. (1) · Kofi Mensah, MD, PhD (1) · Ying Ye, PhD (1)